Belgian chemicals corporation, Solvay, has declared a realignment of manufacturing at its Bad Wimpfen site in Germany, which will effect round 100 jobs.
The corporation will cease manufacturing of trifluoroacetic acid (TFA)-associated organics through early 2026 and some of its inorganics, along with hydrogen fluoride, steadily by the end of 2026. Other product lines in Bad Wimpfen will continue to be unaffected. As a result of this realignment, Solvay could have stopped the manufacturing of TFA and all of its derivatives across the Group by early 2026.
A central element of recent investments in Bad Wimpfen is the establishment of a brand new Nocolok paste & paint facility, followed by the relocation of the Nocolok Tech Centre and manufacturing operations from Garbsen to Bad Wimpfen.
Nocolok refers to a non-corrosive potassium fluoroaluminate flux created through Solvay for brazing aluminium, a process vital for developing heat exchangers.
These steps will combines expertise in one location and establish Bad Wimpfen as a global hub for innovation and consumer applications, supporting Solvay’s position as a global leader in automotive joining.
The measures will result in a net decrease of around 40 positions in Garbsen. The Garbsen site is planned to cease operations by 2028.
Solvay plans to allocate about €25-mn – mainly in 2026 – in restructuring costs and strategic investments.
